Clínica Baviera, S.A. (CBAV.MC)
EUR 34.0
(0.0%)
EUR 34.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 94.98 Million EUR | -45.08% |
| 2022 | 172.94 Million EUR | 14.35% |
| 2021 | 151.24 Million EUR | 40.86% |
| 2020 | 107.37 Million EUR | -2.07% |
| 2019 | 109.64 Million EUR | 13.67% |
| 2018 | 96.45 Million EUR | 8.94% |
| 2017 | 88.54 Million EUR | 10.97% |
| 2016 | 79.79 Million EUR | 7.94% |
| 2015 | 73.92 Million EUR | 3.67% |
| 2014 | 71.3 Million EUR | -0.31% |
| 2013 | 71.52 Million EUR | -10.57% |
| 2012 | 79.97 Million EUR | -3.89% |
| 2011 | 83.21 Million EUR | 3.79% |
| 2010 | 80.17 Million EUR | 6.23% |
| 2009 | 75.46 Million EUR | -5.71% |
| 2008 | 80.03 Million EUR | 10.32% |
| 2007 | 72.55 Million EUR | 20.85% |
| 2006 | 60.03 Million EUR | 38.34% |
| 2005 | 43.39 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 32.52 Million EUR | 100.71% |
| 2024 Q1 | 16.87 Million EUR | -72.48% |
| 2023 Q3 | 47.67 Million EUR | -15.66% |
| 2023 Q2 | 56.52 Million EUR | -4.83% |
| 2023 Q1 | 59.39 Million EUR | 609.14% |
| 2023 Q4 | 61.33 Million EUR | 28.65% |
| 2023 FY | 94.98 Million EUR | -45.08% |
| 2022 Q2 | 11.65 Million EUR | -22.44% |
| 2022 FY | 172.94 Million EUR | 14.35% |
| 2022 Q4 | 8.37 Million EUR | 28.85% |
| 2022 Q3 | 6.5 Million EUR | -44.24% |
| 2022 Q1 | 15.02 Million EUR | -68.59% |
| 2021 Q1 | 11.06 Million EUR | 24.03% |
| 2021 FY | 151.24 Million EUR | 40.86% |
| 2021 Q4 | 47.84 Million EUR | 521.15% |
| 2021 Q3 | 7.7 Million EUR | -32.4% |
| 2021 Q2 | 11.39 Million EUR | 2.97% |
| 2020 Q4 | 8.92 Million EUR | -72.8% |
| 2020 Q2 | 20.2 Million EUR | -31.31% |
| 2020 FY | 107.37 Million EUR | -2.07% |
| 2020 Q3 | 32.79 Million EUR | 62.34% |
| 2020 Q1 | 29.4 Million EUR | -16.1% |
| 2019 Q3 | 27.22 Million EUR | -15.88% |
| 2019 Q1 | 29.69 Million EUR | -0.95% |
| 2019 Q2 | 32.36 Million EUR | 8.97% |
| 2019 Q4 | 35.05 Million EUR | 28.77% |
| 2019 FY | 109.64 Million EUR | 13.67% |
| 2018 Q1 | 28.5 Million EUR | 3.57% |
| 2018 Q3 | 23.14 Million EUR | -16.35% |
| 2018 FY | 96.45 Million EUR | 8.94% |
| 2018 Q4 | 29.98 Million EUR | 29.55% |
| 2018 Q2 | 27.66 Million EUR | -2.92% |
| 2017 Q2 | 25.33 Million EUR | 2.08% |
| 2017 FY | 88.54 Million EUR | 10.97% |
| 2017 Q4 | 27.51 Million EUR | 23.89% |
| 2017 Q3 | 22.21 Million EUR | -12.32% |
| 2017 Q1 | 24.81 Million EUR | 1.62% |
| 2016 Q1 | 24.29 Million EUR | -1.53% |
| 2016 FY | 79.79 Million EUR | 7.94% |
| 2016 Q4 | 24.42 Million EUR | 24.41% |
| 2016 Q3 | 19.63 Million EUR | -15.47% |
| 2016 Q2 | 23.22 Million EUR | -4.43% |
| 2015 Q4 | 24.67 Million EUR | 32.76% |
| 2015 Q1 | 21.77 Million EUR | -6.86% |
| 2015 Q2 | 20.48 Million EUR | -5.94% |
| 2015 Q3 | 18.58 Million EUR | -9.26% |
| 2015 FY | 73.92 Million EUR | 3.67% |
| 2014 Q4 | 23.38 Million EUR | 32.08% |
| 2014 Q2 | 19.78 Million EUR | -9.06% |
| 2014 Q1 | 21.75 Million EUR | 3.77% |
| 2014 FY | 71.3 Million EUR | -0.31% |
| 2014 Q3 | 17.7 Million EUR | -10.51% |
| 2013 Q1 | 24.23 Million EUR | -26.38% |
| 2013 Q3 | 16.67 Million EUR | -7.87% |
| 2013 Q4 | 20.96 Million EUR | 25.72% |
| 2013 FY | 71.52 Million EUR | -10.57% |
| 2013 Q2 | 18.09 Million EUR | -25.33% |
| 2012 Q2 | 22.6 Million EUR | -6.56% |
| 2012 Q3 | 10.17 Million EUR | -55.0% |
| 2012 FY | 79.97 Million EUR | -3.89% |
| 2012 Q1 | 24.18 Million EUR | 0.0% |
| 2012 Q4 | 32.92 Million EUR | 223.74% |
| 2011 FY | 83.21 Million EUR | 3.79% |
| 2010 FY | 80.17 Million EUR | 6.23% |
| 2009 FY | 75.46 Million EUR | -5.71% |
| 2008 FY | 80.03 Million EUR | 10.32% |
| 2007 FY | 72.55 Million EUR | 20.85% |
| 2006 FY | 60.03 Million EUR | 38.34% |
| 2005 FY | 43.39 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 7.75 Million EUR | -1125.071% |